It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 04277cam 2200829Ii 4500
001 ocn949887798
003 OCoLC
005 20220812050217.0
008 160517s2016 enka obf 000 0 eng d
006 m o d
007 cr cnu---unuuu
040 $aN$T$beng$erda$epn$cN$T$dGW5XE$dYDXCP$dAZU$dEBLCP$dKSU$dVT2$dIAD$dJBG$dICW$dZ5A$dILO$dICN$dESU$dIOG$dU3W$dMERUC$dEZ9$dOCLCQ$dWYU$dOCLCO$dOCLCA$dMERER$dOCLCO$dOCLCA$dAUD$dOCLCO$dOCLCQ$dOCLCA$dAJS$dCOM$dOCLCO
019 $a951221690$a1087356032
020 $a9783319282169$q(electronic bk.)
020 $a3319282166$q(electronic bk.)
020 $a331928214X
020 $a9783319282145
020 $z9783319282145
035 $a(OCoLC)949887798$z(OCoLC)951221690$z(OCoLC)1087356032
050 4 $aRC280.B8
060 4 $aQZ 267
072 7 $aHEA$x039000$2bisacsh
072 7 $aMED$x014000$2bisacsh
072 7 $aMED$x022000$2bisacsh
072 7 $aMED$x112000$2bisacsh
072 7 $aMED$x045000$2bisacsh
082 04 $a616.99/449061$223
245 00 $aHandbook of HER2-targeted agents in breast cancer /$cRicardo H Alvarez ... [and more].
250 $aSecond edition.
264 1 $aSwitzerland :$bAdis,$c[2016]
264 4 $c©2016
300 $a1 online resource (xi, 110 pages) :$billustrations
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
504 $aIncludes bibliographical references.
588 0 $aPrint version record.
505 0 $aIntroduction and background biology -- HER2 testing -- HER2-positive breast cancer: neoadjuvant and adjuvant therapy -- HER2-positive metastatic breast cancer: first-line treatment -- HER2-positive metastatic breast cancer: second-line treatment -- Emerging targeted agents for HER2-positive breast cancer.
520 $aThis concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.
650 0 $aBreast$xCancer$xChemotherapy$vHandbooks, manuals, etc.
650 0 $aHER-2 gene$vHandbooks, manuals, etc.
650 2 $aBreast Neoplasms$xdrug therapy
650 6 $aSein$xCancer$xChimiothérapie$vGuides, manuels, etc.
650 6 $aGène HR2$vGuides, manuels, etc.
650 7 $aHEALTH & FITNESS$xDiseases$xGeneral.$2bisacsh
650 7 $aMEDICAL$xClinical Medicine.$2bisacsh
650 7 $aMEDICAL$xDiseases.$2bisacsh
650 7 $aMEDICAL$xEvidence-Based Medicine.$2bisacsh
650 7 $aMEDICAL$xInternal Medicine.$2bisacsh
650 7 $aBreast$xCancer$xChemotherapy.$2fast$0(OCoLC)fst00838266
650 7 $aHER-2 gene.$2fast$0(OCoLC)fst00949827
655 0 $aElectronic books.
655 2 $aHandbook
655 4 $aElectronic books.
655 7 $aHandbooks and manuals.$2fast$0(OCoLC)fst01423877
655 7 $aHandbooks and manuals.$2lcgft
655 7 $aGuides et manuels.$2rvmgf
700 1 $aAlvarez, Ricardo H.,$eauthor.
776 08 $iPrint version:$tHandbook of HER2-targeted agents in breast cancer.$dLondon, UK : Springer Healthcare, 2013$z9783319282145
856 40 $3EBSCOhost$uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1228843
856 40 $3OhioLINK$uhttp://rave.ohiolink.edu/ebooks/ebc/9783319282169
856 40 $3ProQuest Ebook Central$uhttps://public.ebookcentral.proquest.com/choice/publicfullrecord.aspx?p=4528448
856 40 $3SpringerLink$uhttps://doi.org/10.1007/978-3-319-28216-9
856 40 $3SpringerLink$uhttps://link.springer.com/book/10.1007/978-3-319-28216-9
856 40 $3SpringerLink$uhttps://link.springer.com/book/10.1007/978-3-319-28214-5
938 $aEBL - Ebook Library$bEBLB$nEBL4528448
938 $aEBSCOhost$bEBSC$n1228843
938 $aYBP Library Services$bYANK$n12996957
029 1 $aAU@$b000057669646
029 1 $aDEBBG$bBV043893679
994 $aZ0$bIME
948 $hNO HOLDINGS IN IME - 206 OTHER HOLDINGS